Table 3.
Injected Cells | Injury | VEGF, pg/ml | IGF-1, pg/ml | HGF, pg/ml |
---|---|---|---|---|
BMC | Sham | 6.1 ± 1.6 | 573.2 ± 83.7 | 503.6 ± 92.8 |
Treated cells | IRI 1 day | 38.6 ± 5.7* | 1,142.7 ± 228.4* | 1,659.6 ± 164.5* |
IRI 3 days | 41.8 ± 6.2* | 1,173.7 ± 157.7* | 1,704.1 ± 223.8* | |
BMC | IRI 1 day | 7.2 ± 2.6 | 658.6 ± 93.3 | 774.4 ± 108.0 |
IRI 3 days | 7.6 ± 2.2 | 613.7 ± 101.2 | 676.1 ± 103.6 |
Values are mean ± SE; n = 4/group. Sera obtained from mice injected with treated cells or with untreated bone marrow cells (BMC) were examined for levels of VEGF, IGF-1, and HGF at 1 and 3 days post-renal ischemia-reperfusion injury (IRI) or sham operation. Note superphysiological concentrations of circulating VEGF, IGF-1, and HGF in mice injected with treated cells compared with that of untreated BMC injection at 1 or 3 days post-ischemic injury and -cell injection.
P < 0.05.